Anti-cold medication :: Consumers survey results of for 2 quarter of 2019

Consumers survey results of for 2 quarter of 2019 in category

Cold and Flu / Anti-cold medication

The annual ratings by results of Consumers survey calculated as average arithmetic mean rank, obtained in each of 4 quarters of year.

	I quarter (january—march)
	II quarter (april—june)
	III quarter (july—september)
	IV quarter (october—december)

1.	4	Amizon (Farmak)	38.71%	5

2.		Фервекс (Bristol-Myers Squibb)	16.13%	2.08

3.	7	Ergoferon (Materia Medica – Ukraine)	12.90%	1.67

3.	7	Gripex (Delta Medical)	12.90%	1.67

3.	6	Анаферон (Materia Medica – Ukraine)	12.90%	1.67

3.	6	Афлубін (Perrigo)	12.90%	1.67

3.	8	Грип-Хеель (Heel)	12.90%	1.67

3.	7	Флюколд-N (Nabros Pharma)	12.90%	1.67

9.	7	Antiflu (Bayer)	9.68%	1.25

9.	6	Arbidol (OTC-Фарм)	9.68%	1.25

9.	7	Антигрипін (Національна гомеопатична спілка)	9.68%	1.25

9.	~	Комбігрип (ORGANOSYN)	9.68%	1.25

9.	7	Мілістан (Mili Healthcare)	9.68%	1.25

14.	4	Колдрекс (GlaxoSmithKline)	6.45%	0.83

14.	8	Колдфлю Екстра (Genom Biotech)	6.45%	0.83

14.	~	Ринза (Johnson & Johnson)	6.45%	0.83

14.	1	Фармацитрон (Pharmascience)	6.45%	0.83

14.	7	Хелпекс (Movi Health GmbH)	6.45%	0.83

–.	8	~~Вікс Актив (Dr. Reddy’s)~~	~~6.45%~~	~~0.83~~

19.	8	IRS 19 (Abbott Laboratories)	3.23%	0.42

19.	8	Грипмакс (Unipharm, Inc)	3.23%	0.42

19.	~	Грипомед (Red star)	3.23%	0.42

19.	8	Гриппостад (Nizhpharm)	3.23%	0.42

19.	7	Грипфлю (Ananta Medicare Ltd.)	3.23%	0.42

19.		Евкабал бальзам (Esparma)	3.23%	0.42

19.	8	Колдрін (Teva)	3.23%	0.42

19.	5	Маліпін (Vishpha \| Фармацевтична фабрика Vishpha)	3.23%	0.42

19.	3	Терафлю (Novartis OTC)	3.23%	0.42

–.		Rinicold (Shreya Life Sciences)	0.00%	0

–.	8	Лекадол плюс C (Sandoz)	0.00%	0

–.	8	Розтиран (Vishpha \| Фармацевтична фабрика Vishpha)	0.00%	0

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2019, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media.

Advanced reporting booklet about the study, including demographics of the respondents, by regional breakdown, information roll-call of ad hoc judges etc, can also be obtained from managers of the contest.